Cargando…

Association of Systemic Immune-Inflammation Index with Non-Alcoholic Fatty Liver Disease: A Population-Based Cross-Sectional Study

BACKGROUND: The aim of this study was to explore the relationship between systemic immune-inflammation (SII) index with non-alcoholic fatty liver disease (NAFLD) in the general population of the United States (U.S.). METHODS: We conducted a cross-sectional study of subjects in the National Health an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Bi, Liu, Yuee, Yang, Yi, He, Jihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440121/ https://www.ncbi.nlm.nih.gov/pubmed/37605743 http://dx.doi.org/10.2147/RMHP.S419183

Ejemplares similares

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2021)

Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey
por: Hu, Xiao-Yu, et al.
Publicado: (2018)

Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study
por: Fresneda, Sergio, et al.
Publicado: (2022)

Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population
por: SILAGHI, CRISTINA ALINA, et al.
Publicado: (2016)

The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
por: Hu, Haofei, et al.
Publicado: (2022)

Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES
por: Hu, Qinggang, et al.
Publicado: (2023)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
por: He, Li-Hong, et al.
Publicado: (2021)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
por: Kotlyarov, Stanislav
Publicado: (2023)

External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan
por: Yang, Bi-Ling, et al.
Publicado: (2015)

Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study
por: WANG, Qian, et al.
Publicado: (2018)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study
por: Baba, Masaru, et al.
Publicado: (2011)

Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
por: Han, Byoungduck, et al.
Publicado: (2022)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2023)

Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study
por: Tang, Yi, et al.
Publicado: (2022)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2023)

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study
por: Huang, Rui, et al.
Publicado: (2023)

Dietary selenium intake in relation to non-alcoholic fatty liver disease assessed by fatty liver index and hepatic steatosis index; a cross-sectional study on the baseline data of prospective PERSIAN Kavar cohort study.
por: Shojaei Zarghani, Sara, et al.
Publicado: (2023)

Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study
por: GONZÁLEZ-VILLANUEVA, Iris, et al.
Publicado: (2020)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease—A Cross Sectional Study
por: Milovanovic, Tamara, et al.
Publicado: (2019)

Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population
por: Zou, Jiawang, et al.
Publicado: (2022)

The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study
por: Dong, Bu-yuan, et al.
Publicado: (2020)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
por: Katsarou, Angeliki, et al.
Publicado: (2020)

Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
por: Tan, Si-hua, et al.
Publicado: (2023)

The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults
por: Guo, Wen, et al.
Publicado: (2020)

From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
por: Rodríguez-Lara, Avilene, et al.
Publicado: (2023)

Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome
por: Chen, Li-Da, et al.
Publicado: (2019)

Dietary patterns in Brazilian patients with non-alcoholic fatty liver disease: a cross-sectional study
por: Ferolla, Silvia Marinho, et al.
Publicado: (2013)

Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
por: Ma, Dae Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_791rv81ao0tpggkj15tal41i9s